|
CN104557975A
|
|
Methods for preparing everolimus intermediates and everolimus degradation impurities
|
|
CN104530112A
|
|
Method for preparing everolimus intermediate and ethylated impurities thereof
|
|
CN104478803A
|
|
Preparation method of varenicline intermediate and nitroreduction impurity thereof
|
|
CN104447491A
|
|
Pyrrole ring containing hemifumarate as proton pump inhibitor as well as intermediate and pharmaceutical application thereof
|
|
CN104478898A
|
|
Preparation method of everolimus and intermediate of everolimus
|
|
CN104402946A
|
|
Invokana intermediate and preparation method thereof in amorphous form
|
|
CN104860899A
|
|
Lurasidone, or related substances of salt of lurasidone, and preparation method of lurasidone and related substances
|
|
CN104829571A
|
|
Escitalopram oxalate related substance and preparation method thereof
|
|
CN103739537A
|
|
New synthesis method of ezetimibe
|
|
CN103588775A
|
|
Pralatrexate degradation impurity and preparation method thereof
|
|
CN102942573A
|
|
Preparation method of olanzapine
|
